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I M M U N O L O G Y
Bcl11b prevents catastrophic autoimmunity by 
controlling multiple aspects of a regulatory T cell gene 
expression program
Syed Nurul Hasan1,2, Amit Sharma1,2, Sayantani Ghosh1,2, Sung-Wook Hong1,  
Sinchita Roy-Chowdhuri3, Sin-Hyeog Im1,2, Keunsoo Kang4, Dipayan Rudra1,2*
Foxp3 and its protein partners establish a regulatory T (Treg) cell transcription profile and promote immunological 
tolerance. However, molecular features contributing to a Treg-specific gene expression program are still in-
completely understood. We find that the transcription factor Bcl11b is a prominent Foxp3 cofactor with multifaceted 
functions in Treg biology. Optimal genomic recruitment of Foxp3 and Bcl11b is critically interdependent. Genome-wide 
occupancy studies coupled with gene expression profiling reveal that Bcl11b, in association with Foxp3, is primarily 
responsible in establishing a Treg-specific gene activation program. Furthermore, Bcl11b restricts misdirected re-
cruitment of Foxp3 to sites, which would otherwise result in an altered Treg transcriptome profile. Consequently, 
Treg-specific ablation of Bcl11b results in marked breakdown of immune tolerance, leading to aggressive sys-
temic autoimmunity. Our study provides previously underappreciated mechanistic insights into molecular events 
contributing to basic aspects of Treg function. Furthermore, it establishes a therapeutic target with potential im-
plications in autoimmunity and cancer.
INTRODUCTION
The precautionary act of defending self from autoreactive lympho-
cytes, a process termed “immunological tolerance,” is largely accepted 
to be mediated by two nonredundant mechanisms. Elimination of 
autoreactive thymocytes triggered by high-affinity interaction with 
self-antigens includes a class of cell-intrinsic mechanism referred to as 
recessive tolerance. An additional layer of control of overexuberant 
immune response is mediated by specialized classes of immune cell 
types that contribute toward an essential trans-acting mechanism 
termed dominant tolerance. Most prominent among the cell types 
mediating dominant tolerance are the so-called regulatory T (Treg) 
cells, a subset of CD4+ T lymphocytes critical for suppressing auto-
immunity, tissue homeostasis, and uncontrolled immune response 
against pathogens. The X chromosome–encoded transcription factor 
Foxp3, a hallmark of Treg cells, is responsible for establishing a unique 
transcriptional program that functionally and phenotypically dis-
tinguishes them from all other T cell lineages (1).
Despite its unequivocal role in Treg biology, our understanding 
of the molecular basis of Foxp3’s function is still evolving. To deter-
mine the molecular composition of Foxp3-associated macromolecular 
complexes and their physiological relevance in maintaining immune 
homeostasis, we previously performed unbiased proteomic iden-
tification of Foxp3-associated nuclear factors (2). One of the most 
prominent transcription factors that we confirmed to be strongly 
interacting with Foxp3 is the C2H2 zinc finger domain–containing 
transcription factor Bcl11b. Initially identified as a tumor suppressor 
in T cells, Bcl11b in recent years have been implicated in multiple 
aspects of immune-related processes of development and function. 
During hematopoietic development, Bcl11b acts as a checkpoint 
necessary to promote T cell lineage commitment while suppressing 
natural killer cell potential (3). In early stages of T cell development, 
it is necessary for survival of double-negative and double-positive 
thymocytes,  selection, and positive selection of CD4 and CD8 single- 
positive thymocytes (4). It has been shown to suppress T helper 1 
(TH1) differentiation and restrict TH17 cell plasticity by blocking the 
TH2 effector program (5). Furthermore, extending its role beyond 
T cell biology, Bcl11b was also demonstrated to be a critical tran-
scription factor required to maintain the identity and function of 
type 2 innate lymphoid cells (6).
In recent past, primarily using a pan T cell–specific conditional 
knockout model in combination with an adoptive transfer–based 
experimental system, Bcl11b has been implicated in Treg-dependent 
suppression of inflammatory bowel disease, at least part of which is 
mediated by Bcl11b-dependent maintenance of optimal gene expres-
sion of the anti-inflammatory cytokine IL10 and of Foxp3 itself (7). 
While these findings point toward a critical role of Bcl11b in Treg 
suppressive function, precise understanding of the Treg cell–specific 
role of Bcl11b remains unclear, due to delayed and inefficient deletion 
of the loxP-flanked Bcl11b conditional (Bcl11bf/f) allele when crossed 
to mice harboring a bacterial artificial chromosome (BAC) transgene 
encoding Foxp3–enhanced green fluorescent protein–Cre (7).
Because of the strong interaction between Bcl11b and Foxp3 ob-
served in our earlier study (2) and the different lines of physiological 
implications discussed above, here we directly investigate the con-
sequence of conditional ablation of Bcl11b in Treg cells. Notably, we 
find that in contrast to the relatively mild and delayed phenotype ob-
served earlier, efficient deletion of Bcl11b at an early age results in 
drastic whole-body autoimmunity, characterized by an overtly activated 
immune system that is reminiscent of mice in which functional Treg 
cells are absent. In concert to these findings, mechanistic investiga-
tions strongly implicate Bcl11b to be an essential cofactor of Foxp3 
and establish its diverse functions in configuring the gene expression 
network required for mediating Treg homeostasis and function.
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RESULTS
Systemic and lethal autoimmunity upon Treg-specific 
deletion of Bcl11b
To investigate the consequence of conditional ablation of Bcl11b in 
Treg cells, we generated Bcl11bf/fFoxp3IRES-YFP-Cre mice [henceforth 
designated as “KO” and control littermates Bcl11b+/+Foxp3IRES-YFP-Cre 
or Bcl11bf/+Foxp3IRES-YFP-Cre, which are phenotypically indistinguish-
able, designated as “WT” (wild type)] by crossing mice harboring 
Bcl11bf/f allele with Foxp3IRES-YFP-Cre mice expressing yellow fluores-
cent protein (YFP)–Cre recombinase fusion protein under the control 
of Foxp3 regulatory elements. Of note, the Foxp3IRES-YFP-Cre knock-in 
mice were generated independently (8), different from a BAC transgene- 
encoded “Cre”-expressing mouse line used earlier to delete Bcl11b in 
Treg cells (7), which is routinely used for efficient Treg-specific depletion 
of target alleles. In these newly generated KO mice, we observed effi-
cient Treg-specific deletion of Bcl11b, 3 weeks after birth, which was the 
earliest point that they were analyzed (fig. S1A). The KO mice were born 
in expected Mendelian ratios and, more importantly, displayed an overtly 
aggressive autoimmune phenotype characterized by extreme forms 
of lymphadenopathy, splenomegaly, and cellular infiltration in various 
tissues, which led to early mortality within 5 weeks after birth. Overall, 
the extent of autoimmunity in these mice is qualitatively similar to those 
harboring a Foxp3 reporter null allele (Foxp3GFPKO) that leads to com-
plete lack of functional Treg population from birth (fig. S1, B to D) (9).
As expected, analysis of KO mice revealed markedly increased total 
cellularity and increased CD4+ and CD8+ T cell compartments within 
lymph nodes and spleen (Fig. 1, A and B). CD4+Foxp3− population in 
these mice exhibited enhanced expression of a panel of markers known 
to be associated with activation, including CD25, glucocorticoid- 
induced TNFR-related protein (GITR), inducible T-cell co-stimulator 
(ICOS), and cytotoxic T-lymphocyte associated protein 4 (CTLA4) 
(Fig. 1C and fig. S2A). The effector memory population, characterized 
by CD62LloCD44hi, was markedly increased in CD4+Foxp3− and CD8+ 
compartments, as was the percentage of Ki67+ proliferating T cells 
(Fig. 1, D and E). A similar increase was observed in cytokine production 
of both TH1 and TH2 effector types, characterized by interferon- (IFN-) 
and interleukin-4 (IL-4) and IL-13, respectively (Fig. 1F). Furthermore, 
serum concentrations of all the immunoglobulin subtypes examined, 
IgM, IgG, and IgE, were remarkably increased in KO mice compared to 
WT littermates (Fig. 1G). Together, these results demonstrated overt and 
systemic immune dysregulation upon Treg-specific deletion of Bcl11b.
Bcl11b-deficient Treg cells develop normally but are 
compromised for function and homeostasis
The extreme autoimmune phenotype and activated state of the ef-
fector T cell population observed in the KO mice strongly suggested 
an indispensable and nonredundant role of Bcl11b in Treg cell func-
tion and/or homeostasis. Analysis of the CD4+Foxp3+ compartments 
of WT and KO mice revealed that Treg cell frequency, while lightly 
reduced in the spleen, is largely unaffected in the lymph nodes of KO 
mice. Also, the mean fluorescence intensity (MFI) of Foxp3 remained 
unaltered in Bcl11b-deficient Treg cells (Fig. 2A). The effector Treg 
population characterized by CD62LloCD44hi was found to be mar-
ginally increased in KO mice, primarily in the spleen (fig. S2B). Fur-
thermore, the Treg cells displayed higher frequencies of GITR, CTLA4, 
ICOS, and Ki67, indicating heightened activation and proliferation, 
presumably as a consequence secondary to the marked immune 
dysregulation ensuing in these mice (Fig. 2, B and C and fig. S2C). 
These overall characterizations of Treg cells suggested that the ob-
served phenotype of the KO mice is unlikely a result of sheer reduction 
in Treg cell number or due to compromised expression of Foxp3 at a 
per-cell level. We therefore anticipated that Bcl11b might be directly 
associated with Treg cell function. In an in vitro suppression assay, 
Bcl11b-deficient Treg cells displayed an almost complete loss of sup-
pressive capacity compared to their WT counterparts (Fig. 2D).
Next, we employed a cell transfer model of colitis to assess Treg- 
specific functions of Bcl11b in vivo in an inflammatory setting. 
Allelically marked colitogenic CD4+Foxp3−CD45RBhi T cells were 
transferred in RAG1−/− (recombination activating gene 1-deficient) 
recipient mice along with Treg cells isolated from either WT or KO 
mice (Fig. 2E). As shown in Fig. 2F, while cotransfer with WT Treg 
cells could prevent body weight loss, that of Treg cells isolated from 
KO mice could not (Fig. 2F). This was associated with a significant 
increase in IFN-+ effector T cell population in mice harboring 
KO-derived Treg cells (Fig. 2G), suggesting severely compromised 
suppression in these mice. While the ratio between Treg and 
CD45.1+ effector T cells remained unperturbed in the mice that 
received WT Treg cells, we could hardly detect any Bcl11b-deficient 
Foxp3+ Treg population in transferred RAG1−/− recipients at the 
end of the experiment (Fig. 2H). These results suggest that under 
inflammatory settings created by the cell transfer model of colitis, 
Bcl11b deficiency results in severely compromised homeostasis in 
Treg cells, presumably due to enhanced cell death.
The above results raised the question whether homeostasis and 
maintenance of Bcl11b-deficient Treg cells are also affected in a com-
petitive scenario. We therefore examined relative sizes of Bcl11b- 
sufficient and Bcl11b-deficient Treg cell subsets in heterozygous 
Bcl11bf/fFoxp3IRES-YFP-Cre/+ (designated as “het-KO”) and littermate 
Bcl11b+/+ or f/+ Foxp3IRES-YFP-Cre/+ (designated as “het-WT”) female 
mice. Notably, het-KO females are disease free, since owing to X 
chromosome inactivation, only half of the Treg cells express YFP-Cre, 
resulting in deletion of Bcl11b. Analyses of the YFP-Cre+ compart-
ments of Treg cell populations in het-WT and het-KO mice revealed 
that the proportion of peripheral YFP-Cre+ Treg cells was markedly 
reduced in het-KO mice compared to that in het-WT littermates 
(Fig. 2I). Deletion of Bcl11b in the absence of inflammation therefore 
results in diminished competitive fitness of Treg cells when their 
WT counterparts are present. Together, these results strongly sug-
gested that Bcl11b is critical for overall suppressive functions, as well 
as homeostasis and maintenance of Treg cells.
The Treg gene expression program is critically altered 
in the absence of Bcl11b
To acquire an in-depth understanding of the Treg-specific molecular 
functions of Bcl11b, we first wished to determine the transcrip-
tional profile of Bcl11b-deficient Treg cells by high-throughput 
next-generation cDNA sequencing [RNA sequencing (RNA-seq)]. 
Comparing gene expression between WT and KO mice is not ideal 
due to bystander effects arising from overt autoimmunity upon 
Treg-specific deletion of Bcl11b. Therefore, to directly compare the 
cell-intrinsic gene expression profile from Bcl11b-deficient and 
Bcl11b-sufficient Treg cells, we decided to perform RNA-seq analyses 
from cells sorted from het-WT and het-KO mice, where these cells 
reside in comparable noninflammatory conditions. RNA-seq anal-
ysis was performed on CD4+YFP+ cells that were sorted at high 
purity from het-WT and het-KO mice (fig. S3A). In an initial phase 
of analysis, considering the marked loss of Treg cell function in the 
absence of Bcl11b, we examined the expression of several effector 
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molecules that have been implicated in Treg suppressive activity. We 
found that the expression of most of these molecules was markedly 
reduced in het-KO–derived CD4+YFP+ cells compared to those from 
het-WT mice. In agreement with what was reported previously (7), 
IL10 was observed to be one of the most affected genes, with ~10-fold 
reduction in expression. Other affected genes implicated in Treg 
suppressive function were Itgae (encoding CD103), Lag3, Itgb8, Ebi3, and 
Tigit. Nt5e (encoding CD73), Icos, and Tgfb1 were also reduced, albeit 
to a lesser extent (Fig. 3A). Of note, we also observed significant down- 
regulation of genes encoding CD25 (Il2ra) and CTLA4 in het-KO 
compared to het-WT, although the expression of these gene products 
remained unchanged or even increased in KO mice (Fig. 2B and fig. 
S2C). This observation suggested that the overt autoimmune back-
drop in KO mice resulted in up-regulation of these gene products, 
which are otherwise cell intrinsically repressed in the absence of 
Bcl11b under disease-free conditions. Overall, these findings are 
in concert with a gross defect in suppressive capacity of Bcl11b- 
deficient Treg cells and the marked autoimmune phenotype observed 
in KO mice.
We next performed differential gene expression (DGE) analysis 
of the RNA-seq data. Among all the expressed genes (10,349 among 
23,996 genes present), 546 genes were up-regulated (“Up” genes) 
and 356 genes were down-regulated (“Down” genes) ≥1.5-fold in 
het-KO–derived CD4+YFP+ cells compared to that from het-WT 
mice, with a false discovery rate (FDR)–adjusted P value cutoff of 
0.05 (Fig. 3B). Gene Ontology analysis [using Database for Annota-
tion, Visualization and Integrated Discovery (DAVID 6.8) software 
package https://david.ncifcrf.gov/home.jsp] of the “biological-process” 
category on Bcl11b-dependent gene sets revealed, as expected, a 
number of genes implicated in immune-related functions (such as 
Fig. 1. Marked immune dysregulation in Bcl11bf/fFoxp3IRES-YFP-cre mice. (A and B) Total (A) and CD4+ and CD8+ T cell compartment cellularity (B) within indicated sec-
ondary lymphoid organs in 3- to 5-week-old Bcl11bf/fFoxp3IRES-YFP-cre (KO) or littermate Bcl11b+/+Foxp3IRES-YFP-Cre (WT) mice. (C) Representative fluorescence-activated cell 
sorting (FACS) plots showing the expressions of indicated activation markers on CD4+Foxp3− cells in WT and KO mice. Statistical quantification is summarized in fig. S2A. 
(D to F) Representative FACS plots and quantification of CD4+ and CD8+ effector memory CD44hiCD62Llo T cells (D), Ki67+ proliferating CD4+ T cells (E), and cytokine-producing 
CD4+ T cells (F) within indicated lymphoid organs of WT and KO mice. (G) Concentrations of IgM, IgG, and IgE in serum of 3- to 5-week-old WT or KO mice, determined by 
enzyme-linked immunosorbent (ELISA) assay. Data are representative of six to eight mice from two to three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, 
and ****P < 0.0001(Student’s t test; error bars denote SD).
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“Immune system process,” “Inflammatory response,” and “Innate 
immune response”) and processes contributing to cell survival and 
homeostasis (like “Apoptotic process”), as well as genes implicated 
in transcriptional control of gene expression (fig. S3B and table S1).
To determine whether the absence of Bcl11b in Treg cells affects 
the Treg-specific and/or Foxp3-dependent gene expression program, 
we next compared the above DGE dataset with Treg signature genes 
[differentially expressed genes (DEGs) in CD4+Foxp3+ Treg compared 
to CD4+Foxp3− naïve T (Tn) cells], as well as Foxp3-dependent sig-
nature genes [DEGs in CD4+Foxp3+ compared to GFP+ Foxp3-null 
(Tfn) cells derived from Foxp3GFPKO mice] (9, 10). It is well estab-
lished that while many are Foxp3 dependent, the magnitude and 
Fig. 2. Phenotypic analyses of Bcl11b-deficient Treg cells. (A) Representative FACS plot (left), quantification of percentage CD4+Foxp3+ Treg cells (middle), and mean 
fluorescence intensity (MFI) of Foxp3 (right) from cells isolated from 3- to 5-week-old WT or KO mice. (B) Representative FACS plots showing the expressions of indicated 
activation markers on Treg cells in WT and KO mice. Statistical quantification is summarized in fig. S2C. (C) Representative FACS plots and quantification of Ki67+ proliferating 
CD4+Foxp3+ Treg cells isolated from indicated lymphoid organs. (D) In vitro suppression assay, illustrating suppression of T responder (Tresp) cell proliferation by Treg cells 
sorted from WT or KO mice. Histogram represents CTV dilution of labeled sorted Tnv cells alone (no Treg) or cocultured sorted WT- or KO-derived Treg cell populations at 
1:2 Treg/Tresp ratio (left). Cumulative data expressed as CTV MFI of responder CD4+ cells for all the indicated Treg/Tresp coculture ratios normalized against CTV MFI of 
responder cells cultured alone are shown on the right. Data represent two to three independent experiments. *P < 0.05 (Student’s t test; error bars denote SD). (E) FACS 
plots representing mix of sorted YFP+ Treg cells from WT or KO mice, along with colitogenic Ly5.1+CD45RBhi T cells that were transferred in recipient RAG1−/− host mice, 
which were eventually monitored for weight loss, indicative of in vivo suppressive capacity of cotransferred Treg cell populations. (F) Percentage body weight change over 
time of RAG1−/− mice that were cotransferred with Ly5.1+CD45RBhi T cells along with WT- or KO-derived Treg cells. Data are representative of two independent experi-
ments (n = 6 in each group). Mean ± SEM.**P < 0.01 and ***P < 0.001 [two way analysis of variance (ANOVA), Bonferroni posttest]. (G) Intracellular staining for IFN- in 
lymph nodes of representative recipient mice with WT or KO Treg cells that were viable at the end of the experiment. (H) FACS plots (left) and summary (right) of percentage 
of Treg cells remaining in the lymph nodes of representative recipient mice at the end of the experiment. (I) Analyses of Bcl11b-sufficient and Bcl11b-deficient Treg cells in 
heterozygous female Bcl11b+/+Foxp3IRES-YFP-Cre/+ (het-WT) and Bcl11bf/fFoxp3IRES-YFP-Cre/+ (het-KO) mice, in which half of the Treg compartment expresses YFP-cre. *P < 0.05, 
**P < 0.01, ***P < 0.001, and ****P < 0.001; NS, not significant (Student’s t test; error bars denote SD).
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pattern of expression for a large fraction of Treg signature genes are 
shaped independent of Foxp3 (9). We observed that a large propor-
tion of the Bcl11b-dependent Up or Down genes are bonafide Treg 
signatures, whose expressions are negatively altered in the absence 
of Bcl11b. For example, Gata1, Ikzf4, and Irf4, which represent 
“activated” Treg signature, are Down in Bcl11b-deficient Treg cells, and 
genes encoding Pde3b, Tcf4, and Fcer1g, which represent “repressed” 
Treg signature, are Up in Bcl11b-deficient Treg cells (Fig. 3, C and D, 
and table S1).
As expected, a sizable fraction of Bcl11b-dependent genes repre-
senting Treg-signature are also Foxp3 dependent (Fig. 3, C and D, 
underlined genes, and table S1). However, such genes appeared to 
be overrepresented in the Bcl11b-dependent Down gene category 
(116 of 356 Down genes versus 54 of 546 Up genes are Foxp3 de-
pendent). To achieve a more robust understanding, we therefore 
performed a cumulative distribution function (CDF) analysis of the 
difference in expression for gene subsets encoding Treg signature 
genes or Foxp3-dependent genes. A shift in cumulative gene expres-
sion curve to the left and right of the distribution for all expressed 
genes indicate that most of the genes within the respective gene sets 
analyzed were down-regulated or up-regulated, respectively. Quan-
titatively extending our inference above, we found very high and 
significant correlations between cumulative expressions of both 
activated and repressed Treg signature genes with Bcl11b-dependent 
global gene expression patterns (Fig. 3E and table S1). In contrast to 
this observation, when Foxp3-dependent gene sets were considered, 
specifically the Foxp3-dependent activated genes were found to be 
mainly down-regulated in Bcl11b-deficient Treg cells (Fig. 3F and 
Fig. 3. Treg genetic signature is critically dependent on the presence of Bcl11b. RNA-seq analysis was performed on YFP-Cre+ Treg cells sorted from het-WT or het-KO 
mice. (A) Expression of candidate Treg signature genes implicated in suppressive function. Each box represents one of four replicates per group. #P < 10−3 and $P < 10−2. 
P values are for het-KO versus het-WT Treg cells as determined by differential gene expression (DGE) analysis. (B) DGE analysis comparing combined gene expression in 
YFP-Cre+ Treg cells from het-KO versus het-WT. Up and Down signify genes whose expressions are 1.5-fold up-regulated or down-regulated, respectively. (C and D) Heatmaps 
of selective Down (C) or Up (D) genes that also represent bonafide Treg signature genes, clustered according to Gene Ontology analysis. The respective terms for each 
cluster under the “biological process” category are indicated on the left. Underlined genes represent Foxp3-dependent ones, whose expressions are more than 1.5-fold 
altered between wild-type (WT) Treg versus GFP+ Foxp3-null (Tfn) cells derived from heterozygous Foxp3GFPKO/WT females. (E and F) Cumulative distribution function 
(CDF) analyses of gene expression changes between Bcl11b-deficient versus Bcl11b-sufficient Treg cells for gene subsets 1.5 or 2-fold up- or down-regulated in Treg cells 
compared to T naïve (E) or Tfn (F). ****P < 10−16 (two-tailed Kolmogorov-Smirnov test).
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table S1). In agreement with these findings, in an independently 
performed gene set enrichment analysis (GSEA) (11), while Bcl11b- 
dependent Down or Up genes were both found to be overrepresented 
in Treg signature genes when compared to Tn (fig. S3, C and D), 
only the Down genes were found to be significantly enriched within 
“GAVIN_FOXP3_TARGETS_CLUSTER” T4 and P4, which were 
implicated previously by Gavin et al. (9) as “Foxp3-enriched” (fig. 
S3E). Therefore, in terms of molecular functions, while Bcl11b was 
found to contribute to shaping up both activated and repressed 
Treg-specific gene signatures, it primarily appears to promote tran-
scriptional activation as far as Foxp3-dependent gene expression is 
considered.
Collectively, these results strongly establish Bcl11b-dependent 
gene expression as a mainstay of Treg transcriptional program, the 
disruption of which results in catastrophic breakdown of systemic 
tolerance even at resting state. Furthermore, considering the extent of 
colossal alteration of global genetic signature, it seemed implausible 
that the functional incompetence of Bcl11b-deficient Treg cells is 
likely to be rectified by modulating the expression of any specific 
gene product.
Large overlap between Bcl11b- and Foxp3-bound sites 
in Treg cells
To identify Bcl11b-associated genes in Treg cells, we next performed 
genome-wide chromatin immunoprecipitation followed by next- 
generation sequencing (ChIP-seq). In addition to CD4+Foxp3+ Treg 
cells, we performed Bcl11b ChIP-seq analysis on CD4+Foxp3− 
Tn cells as well. Initial analysis identified 270 among 902 of the DEGs 
in Treg cells (37% among Down genes and 25% among Up genes) to be 
bound by Bcl11b within ± 20 kb of their respective transcription start 
sites (TSSs) (Fig. 4A and table S2), suggesting direct Bcl11b-mediated 
regulation. Furthermore, while majority of the Bcl11b-associated 
peaks in Treg cells were common to that in Tn (Tn/Tr-common), 
~31% of the sites were found to be unique for Treg cells (Tr-specific) 
(Fig. 4, B and C). Many of the Tr-specific sites, upon manual inspec-
tion, appeared to be associated with prominent genes implicated in 
Treg homeostasis and function (Fig. 4C, right, and table S2). We 
therefore sorted to determine whether any correlation exists between 
Tn/Tr-common or Tr-specific Bcl11b-bound genes, with respect to 
the directionality of their corresponding gene expression changes. 
We found that Tr-specific sites were significantly enriched within 
genes whose expressions are down-regulated in the absence of Bcl11b 
(Fig. 4D, bottom). In contrast, Tn/Tr-common sites showed mar-
ginal enrichment on up-regulated genes (Fig. 4D, top). For both cases, 
however, the enrichment for Up or Down genes was significantly 
higher than that for randomly selected genes, suggesting that while 
there is significant biasness for Tr-specific genes to be down-regulated 
in the absence of Bcl11b, this is not a rule (Fig. 4D). In agreement 
with these results, a CDF analysis of gene expression changes for the 
genes exclusively bound by Bcl11b in a Tr-specific manner showed 
a significant shift toward the left (Fig. 4E and table S2). In line with 
these findings, transcription factor motif analysis also revealed dif-
ferences in motif enrichment among the two categories of sites. For 
example, while the Tn/Tr-common sites are highly enriched for ETS 
(E-twenty-six) DNA-binding domain, with more than 44% of the 
sites having Elk1 (ETS) motif ±100 base pairs (bp) of Bcl11b peaks, 
the ETS motifs are significantly underrepresented (~14% targets) 
near the Bcl11b peaks in the Tr-specific sites. On the other hand, 
binding motifs for the CCAAT/enhancer-binding protein  (~23% 
targets) were found to be overrepresented near the Tr-specific Bcl11b 
peaks (fig. S4, A and B).
Provided the large overlap between Treg and Foxp3-dependent 
signatures with gene expression changes in Bcl11b-deficient Treg 
cells, we next performed Foxp3 ChIP-seq to determine whether 
Bcl11b and Foxp3 bind to similar sites. We found that ~65% of 
Bcl11b-bound sites were also bound by Foxp3. We termed them 
“Bcl11b-Foxp3-Overlapping” and the sites bound by Bcl11b alone 
as “Bcl11b-specific” sites (Fig. 4, F and G, and table S3). For Foxp3-
bound sites, relatively less than ~33% were found to have high 
enrichment for Bcl11b peaks. The remaining sites where Bcl11b 
peaks were not called for still showed slight but detectable enrich-
ment for Bcl11b binding (Fig. 4F), suggesting loose or transient 
association. As observed for Tr-specific Bcl11b-bound genes, Bcl11b- 
Foxp3-Overlapping sites were found to be highly enriched on 
Bcl11b-dependent Down genes (Fig. 4H, bottom, and table S3). 
Bcl11b-specific sites, on the other hand, were overrepresented on 
Up genes (Fig. 4H, top, and table S3).
Together, these results collectively led to the following conclu-
sions. While most of the Bcl11b-associated sites are carried over 
from precursor Tn to Treg, a fraction of Bcl11b is “redistributed” to 
specific sites in Treg cells. Furthermore, in light of the observed ex-
pression changes of the genes that are cobound by Bcl11b and Foxp3 
[with Bcl11b-Foxp3-Overlapping sites (Fig. 4H)], it seemed likely 
that in these Tr-specific sites, Bcl11b is recruited, presumably by 
interacting with Foxp3, to enhance the expression of genes relevant 
for Treg function and homeostasis. In agreement with this notion, 
upon reexamining previously published ChIP-seq data (12), we ob-
served higher enhancer activity indicated by higher enrichment of 
H3K27 acetylated (H3K27ac) and H3K4 monomethyl (H3K4me1) 
chromatin modification marks associated with genes harboring 
Bcl11b-Foxp3-Overlapping sites that are Tr specifically bound by 
Bcl11b, compared to genes that are exclusively bound only by Bcl11b 
(with Bcl11b-specific sites) (Fig. 2I, middle and top). H3K27 trimethyl 
(H3K27me3) chromatin marks, on the other hand, showed no dif-
ference among the two groups (Fig. 4I, bottom). This was associated 
with a highly significant negative shift in cumulative expression for 
genes harboring Tr-specific Bcl11b-Foxp3-Overlapping sites. In con-
trast, genes exclusively harboring Bcl11b-specific sites were signifi-
cantly up-regulated upon its deletion, suggesting a primarily repressive 
role of Bcl11b, when it is bound in a Foxp3-independent manner 
(Fig. 4J and table S3).
Optimal recruitment of Bcl11b in Treg cells is  
dependent on Foxp3
The large overlap between Foxp3 and Bcl11b binding sites in Treg 
cells raised the possibility that the genomic occupancy of these two 
factors may be mutually dependent on each other. We first asked 
whether Bcl11b’s binding to its genomic sites is dependent on Foxp3. 
To this end, we performed ChIP-seq analysis for Bcl11b binding 
in Tfn cells derived from Foxp3GFPKO mice. Compared to WT Treg 
cells, Bcl11b’s binding to majority (~60%) of its sites was found to 
be markedly reduced in Tfn cells (Fig. 5A and table S4), suggesting 
direct or indirect dependence on Foxp3. Upon manual inspection 
of randomly selected representative Tn/Tr-common and Tr-specific 
Bcl11b binding sites, we observed that, to a large extent, the peaks 
that were otherwise gained by Bcl11b in Treg cells compared to Tn 
(Tr-specific sites) were the ones that were significantly reduced in 
the absence of Foxp3. For example, while Tr-specific Bcl11b binding 
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Fig. 4. Large overlap between Bcl11b- and Foxp3-occupied sites in Treg cells. ChIP-seq was performed for Bcl11b on sorted CD4+Foxp3+ Treg (Tr) and CD4+Foxp3−CD62lhi 
T naïve (Tn) cells. (A) Overview of the percentage of Bcl11b-dependent Up or Down genes bound by Bcl11b within ±20 kb of their transcription start sites (TSSs). (B) Genome-wide 
occupancy of Bcl11b in Tr and Tn cells. Each column depicts Bcl11b binding in Tr or Tn cells within a window ±3 kb centered around Bcl11b-bound sites (indicated as a 
yellow triangle). Normalized enrichments of indicated Bcl11b-bound peak sets are shown on the right as histogram plots. (C) Representative tracks, as viewed in Integrative 
Genome Viewer (IGV), of Bcl11b ChIP-seq reads aligned to the corresponding gene loci. Y scale is normalized tag intensity (reads per million mapped reads). Red arrows 
point toward peaks in each category that are otherwise not obvious. (D) Plots depicting enrichment of Tn/Tr-common (top) or Tr-specific (bottom) sites within a given 
distance to promoter of randomly selected genes, or genes that are down-regulated or up-regulated in Bcl11b-deficient Treg cells. Wilcoxon rank-sum test P values are 
shown. (E) CDF analysis of gene expression changes between Bcl11b-deficient versus Bcl11b-sufficient Treg cells for gene subsets that “exclusively” contain Tr-specific 
Bcl11b-specific sites. Of note, there was a subcategory of genes prebound by Bcl11b in Tn and gained new Bcl11b peaks at different site(s) in Tr. While these genes are also 
categorized as Tr-specific site–containing genes, they are not included in this analysis. Two-tailed Kolmogorov-Smirnov test P value is shown. (F) Genome-wide occupan-
cy of Bcl11b and Foxp3 in Treg cells. Each column depicts Bcl11b or Foxp3 binding within a window ±3 kb centered on peaks identified by ChIP-seq analyses (indicated as a 
yellow triangle). Normalized enrichments of indicated Bcl11b- and Foxp3-bound peak sets are shown on the right as histogram plots. (G) Examples of Bcl11b- and Foxp3-
bound peaks representing common sites (Bcl11b-Foxp3-Overlapping) or sites where Bcl11b binds in the absence of Foxp3 (Bcl11b-specific). (H) Plots depicting enrichment 
of Bcl11b-specific (top) or Bcl11b-Foxp3-Overlapping (bottom) sites within a given distance to promoter of randomly selected genes, or genes that are down-regulated 
or up-regulated in Treg cells in the absence of Bcl11b. (I) Normalized enrichment of indicated chromatin marks around Bcl11b binding sites within ±20 kb of TSS for the gene 
subsets analyzed. The blue line represents genes with Bcl11b-Foxp3-Overlapping sites that are Tr-specific for Bcl11b. The red line represents genes that are only bound by 
Bcl11b in Treg cells. (J) CDF analysis of gene expression changes between Bcl11b-deficient versus Bcl11b-sufficient Treg cells for indicated gene subsets. Genes that are 
bound by both Bcl11b and Foxp3, but at two different sites (nonoverlapping), are excluded from this analysis. Two-tailed Kolmogorov-Smirnov test P values are shown.
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sites on Ctla4, Il2ra, Tigit, Foxp3, and Mrpl22 are lost (Fig. 5B, right), 
among the Tn/Tr-common sites tested, only the site corresponding 
to Ifnar1 was reduced. On the other hand, Bcl11b sites on Med4, 
Wdr70, Uba5, and Gins4 were still retained in Tfn (Fig. 5B, left). In 
agreement with these observations, quantitative analysis revealed 
that 84% of Tr-specific sites, as opposed to 39% of Tn/Tr-common 
sites corresponding to genes expressed in Treg cells, were lost in Tfn 
compared to WT (Fig. 5C and table S4).
Somewhat counterintuitively, among the Tr-specific sites lost, 
only ~15% were found to be sites that were cobound by Foxp3 and 
Bcl11b in WT Treg cells (Bcl11b-Foxp3-Overlapping) (Fig. 5C). 
Underscoring their functional relevance, however, a CDF analysis 
of the corresponding genes harboring such sites showed that these 
genes are significantly down-regulated in Bcl11b-deficient Treg cells 
(Fig. 5D, right, and table S4). Therefore, in line with the conclusions 
from results obtained so far, Bcl11b appears to be recruited to a 
relatively small fraction of newly occupied Tr-specific sites by virtue 
of direct interaction with Foxp3 to promote active gene expression. 
These results also suggest that Bcl11b occupies the remaining 85% 
of Tr-specific sites by mechanisms that are indirectly dependent on 
Foxp3, for example, by interacting with transcription factors whose 
optimal expression and genomic occupancy in Treg cells are, in turn, 
dependent on Foxp3. However, unlike the Bcl11b-Foxp3-Overlapping 
sites, the functional relevance of Bcl11b binding to these Bcl11b- 
specific sites is not clear, since a CDF analysis did not reveal any 
biasness for Bcl11b-dependent active or repressed gene expression 
state for the corresponding gene set (Fig. 5D, right, and table S4).
In contrast to Tr-specific peaks, a significantly larger proportion 
(~64%) of the Tn/Tr-common Bcl11b peaks lost in Tfn cells were 
found to be co-occupied by Bcl11b and Foxp3 in WT Treg (Fig. 5C) 
and collectively showed a negative shift in CDF analysis (Fig. 5D, 
left, and table S4). The remaining 36%, on the other hand, displayed 
a shift toward the right (Fig. 5D, left, and table S4). Therefore, simi-
lar to Tr-specific sites, even for the Bcl11b sites carried over in Treg cells 
Fig. 5. Foxp3 promotes functional recruitment of Bcl11b in Treg cells. (A) Genome-wide occupancy of Bcl11b in WT Treg (Tr) and Tfn cells derived from Foxp3GFPKO mice. 
Bcl11b binding within a window ±3 kb centered on peaks identified by ChIP-seq analyses (indicated as a yellow triangle). Normalized enrichments of indicated Bcl11b 
peak sets are shown on the right as histogram plots. (B) Examples of Bcl11b peaks in Tn, Tr, and Tfn cells as viewed in IGV, representing the indicated categories. Red arrows 
indicate peaks that are significantly reduced in Tfn cells compared to Tr. (C) Graphical representation summarizing the subcategories to which the Bcl11b peaks lost in Tfn 
cells belong. (D) CDF analysis of gene expression changes between Bcl11b-deficient versus Bcl11b-sufficient Treg cells for indicated gene subsets. Two-tailed Kolmogorov- 
Smirnov test P values are shown.
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from Tn, Bcl11b appears to gain stability in genomic association and 
promote gene activation in association with Foxp3. On the other hand, 
in agreement with previous results, the Bcl11b carried over sites where 
it is bound independent of Foxp3; it most likely acts as a repressor.
Genomic association of Foxp3 is altered in the absence 
of Bcl11b
Finally, to ask whether genome-wide occupancy of Foxp3 is affected 
in the absence of Bcl11b, we performed ChIP-seq analysis for Foxp3 
binding in Bcl11b-deficient Treg cells. While ~68% of Foxp3 occupied 
sites were found to be retained (termed “Unaltered”), the binding in-
tensities of the remaining 32% of Foxp3 peaks were significantly re-
duced in KO compared to WT Treg (termed “Lost”). In addition to 
this, we also observed a large number of newly formed sites where 
Foxp3 binding is markedly increased only in Bcl11b-deficient Treg 
cells (termed “Gained”) (Fig. 6, A and B; fig. S5A; and table S5).
To determine the functional relevance of these sites, we first 
focused on the Lost sites. Twenty-six percent of the Lost sites were 
found to be co-occupied by Bcl11b and Foxp3 in WT Treg cells 
(Fig. 6C), suggesting that optimal Foxp3 binding to these sites 
are directly dependent on Bcl11b. In agreement with previous find-
ings, a CDF analysis revealed that the expressions of genes cor-
responding to these sites are negatively affected in the absence of 
Bcl11b (Fig. 6D, blue line, and table S5). The expressions of the 
genes corresponding to the remaining 74% of the Lost sites were 
also found to be dependent on Bcl11b for their optimal activation, 
albeit to a lesser extent (Fig. 6D, red line, and table S5). For these gene 
subsets, therefore, Bcl11b mediates optimal Foxp3 binding either by 
directly associating with it or by indirectly promoting its recruit-
ment, thereby positively affecting the expression of corresponding 
gene products.
Among the 1863 genes harboring a total of 2312 Gained sites, 
1176 were found to be expressed genes. We considered the possibility 
that Bcl11b might be competitively restricting Foxp3’s binding by itself 
being associated to these sites. However, only a very tiny fraction of 
them (1.6%) were found to be Bcl11b-bound in WT Treg cells (Fig. 6E). 
The remaining 98.4% are sites that are not associated with either 
Bcl11b or Foxp3 in WT Treg cells. Notably, by CDF analysis, we found 
that most of these genes are up-regulated in Bcl11b-deficient Treg cells 
(Fig. 6F and table S5). To get a better understanding of their biological 
functions, we curated the candidate genes that gained Foxp3 sites, 
as well as 1.5-fold Up in Bcl11b KO Treg cells (table S5). Many of 
these genes were found to encode factors implicated in signal trans-
duction and innate immune response (fig. S5B and table S5). For 
example, Fcer1g, the gene encoding the Fc fragment of the IgE 
receptor, was found to be more than 200-fold up-regulated in 
Bcl11b-deficient Treg cells (Fig. 6B, right, and table S5). Chemokine 
receptors Ccr3 and Cxcr6 were up-regulated two- to fivefold. Major 
histocompatibility complex II  subunit H2-Aa was found to be 
up-regulated more than fivefold. Expression of Batf3, a transcription 
factor implicated in CD8+ dendritic cell generation and functions 
(13), was up-regulated eightfold (Fig. 6B, right, and table S5). These 
results therefore reveal an interesting function of Bcl11b whereby it 
restricts misdirected recruitment of Foxp3 to genomic sites, for ma-
jority of which it would otherwise promote erroneous expression of 
genes irrelevant for Treg function. As opposed to these Up genes, 
among the relatively fewer candidates that gained Foxp3 binding 
sites and were down-regulated in a Bcl11b-dependent manner, we 
found important genes implicated in Treg functions like Il10, Ctla4, 
Dusp4, Tigit, and Lag3 (fig. S5C) (8, 14–18). Therefore, for this sub-
category, erroneous binding of Foxp3 to these gene loci in the ab-
sence of Bcl11b appears to contribute to their repressive state.
Last, to determine whether Bcl11b affects Foxp3’s recruitment to 
the Lost or Gained sites by influencing chromatin accessibility, we 
performed assay for transposase-accessible chromatin using sequenc-
ing (ATAC-seq) on Treg cells sorted from WT and KO mice. Analysis 
of candidate genes revealed a notable correlation between the con-
sequences of Bcl11b-dependent Foxp3’s binding, with the chromatin 
accessibility of associated sites. The Lost sites were primarily asso-
ciated with reduced chromatin accessibility, whereas Gained sites were 
associated with increased chromatin accessibility (Fig. 6B, middle 
and right, and fig. S5, A and C). On the other hand, accessibility of 
the candidate sites analyzed, where Foxp3 binding remained un-
altered, were mostly unchanged (Fig. 6B, left). Furthermore, global 
analysis of ATAC-seq peaks altered in Bcl11b-deficient Treg cells 
substantiated this observation genome-wide (Fig. 6, G and H, and 
table S5). Together, these results strongly suggest that, to a large extent, 
genomic association of Foxp3 is governed as well as regulated by Bcl11b 
by its ability to modulate the accessibility of corresponding sites. In some 
cases, accessibility to chromatin enables Foxp3’s binding, whereas in 
other cases, Foxp3’s association to inappropriate regions is restricted 
by actively maintaining the closed chromatin conformation of these 
sites. Bcl11b appears to critically influence both the scenarios.
DISCUSSION
Despite being the key component critical for establishing a Treg 
transcription program, it is now clear that like most lineage-specifying 
factors, Foxp3 exerts its effects by forming molecular complexes with 
protein partners it interacts with (2). Provided the current knowl-
edge on the diversity in functions and localization of Treg cells (19), 
as well as the transcriptional modalities that appear to fine-tune 
their genetic makeup (20), it is understandable that, in many cases, 
such interactions are context dependent and presumably transient. 
In stark contrast, the data presented here establish Bcl11b as a 
major transcription factor that either independently, or to a large ex-
tent by serving as a critical cofactor of Foxp3, sets up key functional 
aspects of the Treg-mediated suppressive program.
Conditional deletion of many Foxp3-interacting transcription 
factors have been shown to result in specific alterations in Treg func-
tions, leading to distinct, in some cases subtle or redundant pheno-
typic consequences. For example, compromising transcriptional 
activity of the Runt-related transcription factor family of RUNX 
proteins by depleting their non–DNA-binding subunit Cbf led to 
relatively moderate lymphoproliferative disorder, splenomegaly, and 
increased activation of effector T cells, largely resulting from defec-
tive maintenance of Foxp3 itself (21). While the phenotype was signifi-
cantly more pronounced in BALB/c background, which developed 
gastritis and displayed elevated cytokine production, the overall 
extent of autoimmunity was considerably less than mice devoid of 
functional Treg population (22). As opposed to Runx proteins, in 
accordance with an effector response-specific functional heteroge-
neity among Treg cells, ablation of the interferon regulatory factor 
Irf4, the transcription factor Stat3, or the TH1 cell lineage-specifying 
factor T-bet in Treg cells resulted in mice with selective TH2, TH17, 
and TH1 pathologies, respectively (23–25). In line with these find-
ings, Treg-specific deletion of Bcl6 resulted in compromised sup-
pression specifically of follicular helper T cells (26). Extending the 
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context-dependent functional significance of Foxp3-interacting fac-
tors, peroxisome proliferator–activated receptor , a transcription 
factor well known for its role in adipocyte differentiation, was im-
plicated specifically in adipose tissue–resident Treg homeostasis and 
function (27). Another example underscoring functional redundancy 
among transcription factors in Treg function is the finding that while 
Treg-specific deletion of T-bet or Gata3 independently results in rela-
tively subtle phenotype, combined deletion of both in Treg cells re-
sulted in enhanced autoimmunity, albeit relatively less than observed 
in mice with nonfunctional Foxp3 protein (28). In contrast to these 
findings, however, efficient deletion of Bcl11b in our experiments 
resulted in systemic disruption of Treg function, leading to catastrophic 
Fig. 6. Bcl11b promotes intensity and assures fidelity of Foxp3-bound sites in Tregcells. (A) Genome-wide binding intensity of Foxp3 in WT and Bcl11b-deficient (KO) 
Treg cells. Foxp3 binding within a window ±3 kb centered on peaks identified by ChIP-seq analyses (indicated as a yellow triangle). Normalized enrichments of indicated 
Foxp3-bound peak sets are shown on the right as histogram plots. (B) IGV tracks of Foxp3-bound peaks and corresponding ATAC-seq peaks of the indicated categories 
in WT- and KO-derived Treg cells. (C and E) Graphical summary demonstrating Bcl11b or Foxp3 binding preference in WT Treg cells, for genes harboring Foxp3 peaks lost 
(C) or gained (E) in KO. (D and F) CDF analysis summarizing gene expression changes between Bcl11b-deficient and Bcl11b-sufficient Treg cells for indicated gene subsets 
categorized in (C) and (E), respectively. Two-tailed Kolmogorov-Smirnov test P values are shown. (G) Summary of ATAC-seq peaks in WT and KO Treg cells. (H) Graphical 
representation summarizing the subcategories to which the ATAC-seq peaks lost or gained in Bcl11b-deficient Treg cells belong.
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autoimmune phenotype almost indistinguishable to Foxp3GFPKO mice. 
Looking at the extreme phenotypic consequence, it seems unlikely 
that the devastating breakdown of tolerance in Bcl11bf/fFoxp3IRES-YFP-cre 
mice is a consequence of alteration in any single Treg-mediated sup-
pression mechanism. We propose that Treg-specific deletion of 
Bcl11b results in near-complete crash down of its genetic signature, 
leading to disruption of multiple suppressive modalities that is, to 
an extent, almost similar to that resulting from functional ablation 
of Foxp3 itself.
In terms of physical distribution of Bcl11b to its binding sites, 
while majority of sites were carried over from naïve T cells, almost a 
third were found to be Treg cell specific. The underlying mechanism 
of such redistribution of Bcl11b is not entirely clear. However, it is 
not unlikely that three-dimensional rearrangements of higher-order 
genomic architecture during Treg development results in efficient 
binding of Bcl11b to these sites, where otherwise it is loosely or 
transiently associated in precursor cells. In this regard, a recent study 
reported that during thymic development of T cells, the Bcl11b gene 
locus itself, via a non-coding RNA termed ThymoD, is repositioned 
from nuclear lamina to its interior, resulting in chromatin folding 
and compartmentalization, eventually leading to its transcriptional 
activation (29). The affinity of Bcl11b for a large proportion of its 
associated sites was found to be greatly reduced in the absence of 
Foxp3. While majority of them represent Treg-specific binding sites 
of Bcl11b, many of them also included sites where Bcl11b was pre-
bound in naïve T cells. These results strongly indicate that, to a large 
extent, the association of Bcl11b to its binding sites in Treg cells is 
stabilized directly or indirectly in a Foxp3-dependent manner.
Our results put forward the following molecular contributions 
of Bcl11b with regard to its role in shaping up the Treg cell transcrip-
tional profile. We found a large overlap between Foxp3 and Bcl11b 
binding sites, for majority of which RNA-seq data largely correlate 
with down-regulation of associated genes in the absence of Bcl11b. 
These observations suggest that the Bcl11b-Foxp3 gene regulatory 
axis is a key determinant of the gene activation program in Treg cells. 
On the other hand, in most cases, Bcl11b’s binding in the absence of 
Foxp3 correlates with repressive states of the corresponding genes. 
Provided that Bcl11b has been previously mainly implicated in re-
pressing gene expression by being associated with the nucleosome 
remodeling and deacetylase corepressor complex (30), it appears that 
in association with Foxp3, extensive rearrangements take place in 
the molecular composition of its associated factors.
The absence of Bcl11b in Treg cells resulted in interesting con-
sequences as far as Foxp3’s genome-wide association is concerned. 
First, the optimal binding of Foxp3 is reduced in a subset of its asso-
ciated sites. In accordance to a mechanism suggesting the direct 
involvement of Bcl11b in stabilizing functionally relevant binding 
of Foxp3, a sizable fraction of these sites are co-occupied by Foxp3 
and Bcl11b in WT Treg cells. Furthermore, these sites display re-
duction in ATAC-seq peaks in Bcl11b-deficient Treg cells compared 
to WT, suggesting Bcl11b’s role in promoting chromatin accessibility. 
These sites also cumulatively correlate with reduced expression of 
the corresponding gene products upon depletion of Bcl11b. Second, 
the absence of Bcl11b further results in ectopic association of Foxp3 
to sites where it is otherwise not bound in WT Treg cells. Such 
newly formed sites, in turn, correlate with altered expressions of 
associated genes, as well as enhanced chromatin accessibility in 
Bcl11b-deficient Treg cells compared to WT, thereby suggesting a 
novel role of Bcl11b in restricting erroneous genomic association of 
Foxp3 to maintain Treg-specific steady-state gene expression profile. 
This phenomenon is reminiscent of a recent finding where the tran-
scription factor PU.1 was found to redirect partner transcription 
factor bindings from sites, which the latter would otherwise prefer 
if PU.1 was absent (31). Together, these results strongly establish that 
Bcl11b, either directly by recruiting Foxp3 or indirectly by positively 
or negatively influencing chromatin accessibility, may contribute to 
Foxp3’s optimal occupancy to its binding sites. In this regard, whether 
Bcl11b-dependent changes in chromatin accessibility are also influ-
enced by its potential contribution toward short- or long-range 
chromatin looping remains to be investigated.
In conclusion, this study establishes Bcl11b as a cardinal factor 
defining molecular signatures of Treg cells. We propose that both by 
serving as a “core” component of the otherwise heterogeneous Foxp3 
interactome and by exerting its repressing effect on transcription in a 
Foxp3-independent manner, Bcl11b is critically involved in shaping 
up key functional features of Treg transcriptome. In the future, fur-
ther refinements of mechanisms involved and identification of its 
Treg-specific molecular partners would be instrumental in deciphering 
novel components contributing to immune homeostasis. Further-
more, developing unique strategies to disrupt interaction between 
Foxp3 and Bcl11b, ideally in a tumor-specific manner, might prove 
to be of great therapeutic relevance in cancer immunotherapy.
MATERIALS AND METHODS
Mice
All mice were generated on or backcrossed to C57BL/6 background. 
The Bcl11bf/f mice line (32) was a gift from P. Liu (then at Wellcome 
Sanger Institute). Foxp3IRES-YFP-Cre mice (8) and Foxp3GFPKO mice (9) 
are described elsewhere. All animals were maintained in specific 
pathogen–free barrier facilities and were used in accordance with 
Institutional Animal Care and Use Committee protocols approved 
by the POSTECH Institutional Animal Care and Use Committee.
FACS staining and antibodies
For surface staining, fluorochrome-conjugated antibodies were purchased 
from eBioscience, BioLegend, Tonbo Biosciences, and R&D Bio-
sciences. Anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti-CD25 (PC61.5), 
anti-GITR (DTA-1), anti-ICOS (C398.4A), anti-CTLA4 (UC10-4B9), 
anti-Ki67 (16A8), anti-CD62L (MEL-14), and anti-CD44 (IM7) were 
used in the study. For intracellular staining, surface-stained cells were 
fixed and permeabilized with a Foxp3 staining kit (eBioscience) ac-
cording to the manufacturer’s instructions and were stained with the 
following antibodies: anti-Foxp3 (FJK-16s), anti-IFNg (XMG1.2), 
anti–IL-17A (eBio17B7), anti–IL-4 (11B11), and anti–IL-13 (eBio13A) 
wherever applicable. Stained cells were analyzed using an LSRFortessa 
SORP flow cytometer with Data-Interpolating Variational Analysis 
software (BD Biosciences) and FlowJo (TreeStar).
Histology
Mouse tissues were fixed in 10% formalin, buffered neutrally, and 
were processed with hematoxylin and eosin staining. Blinded assess-
ment of at least three sections of each tissue per mouse was performed 
by an expert pathologist.
Adoptive transfer–induced colitis
Splenic CD4+Foxp3−CD45RBhi cells were sorted from Foxp3GFPCD45.1+ 
mice and mixed with Treg cells sorted from lymph nodes and spleens 
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of Bcl11b+/+Foxp3IRES-YFP-Cre or Bcl11bfl/flFoxp3IRES-YFP-Cre mice. Colitis 
was induced in RAG1-deficient hosts by intravenous injection of 
8 × 105 CD45RBhi + 2 × 105 Treg cells. Mice weight was recorded 
blindly once a week for 8 weeks.
RNA-seq library preparation
CD4+YFP+ cells from heterozygous female Bcl11b f/fFoxp3YFP-Cre/+ 
(het-KO) or littermate Bcl11bf/+ or +/+Foxp3YFP-Cre/wt (het-WT) mice 
were sorted at >97% purity using a BD Moflo-XDP cell sorter. Total 
RNA was extracted using the RNeasy Micro Kit (Qiagen-74004). 
Integrity and concentration of purified RNA were checked using the 
Agilent RNA 6000 Nano Kit (5067-1511) in Agilent BioAnalyzer 
and Nanodrop, respectively. Library was prepared from total RNA 
using the TruSeq Stranded Total RNA kit (Illumina-RS-122-2001) 
following the manufacturer’s protocols. Briefly, cDNA was made from 
total RNA followed by adenylation, barcoded adaptor ligation, and 
polymerase chain reaction (PCR) amplification (15 cycles). Libraries 
were size-selected for 200- to 300-bp fragments using Agencourt 
AMPure XP beads (A63880), and size distribution was confirmed 
using the Agilent High Sensitivity DNA Kit (5067-4626) in Agilent 
BioAnalyzer. Equivalent amounts of barcoded libraries were pooled 
and sequenced using HiSeq 2500 or MiSeq (Illumina) instruments.
RNA-seq analysis
The quality of sequenced reads (50 bp; paired-end) was measured 
using FastQC (www.bioinformatics.babraham.ac.uk/projects/fastqc/), 
and low-quality portions of the sequenced reads were trimmed using 
Trim Galore (version 0.4.2; www.bioinformatics.babraham.ac.uk/
projects/trim:galore/) with Cutadapt (version 1.12) (MARTIN, 
Marcel. Cutadapt removes adapter sequences from high-throughput 
sequencing reads. EMBnet.journal, [S.l.], v. 17, n. 1, p. pp. 10-12, 
May 2011. ISSN 2226-6089. Available at: https://journal.embnet.
org/index.php/embnetjournal/article/view/200/479. Date accessed: 
28 Sept. 2018. doi: https://doi.org/10.14806/ej.17.1.200). The trimmed 
reads were mapped to the mouse genome (reference assembly mm10) 
using STAR (version 2.5.1) (33). The abundances of reference genes 
were estimated using Cuffnorm (version 2.2.1) and DEGs between 
conditions were identified using Cuffdiff (version 2.2.1) with an 
FDR-adjusted P value cutoff of 0.05 (34). The fragments per kilobase 
of transcript per million mapped reads values were used to compare 
gene expression levels.
ChIP-seq library preparation
For Bcl11b ChIP-seq in WT Treg and WT Tn or Tfn cells, 1 × 107 Treg 
and Tn or CD4+GFP+ Tfn cells were sorted from Foxp3IRES-YFP-Cre or 
Foxp3GFPKO mice, respectively. For Foxp3 ChIP-seq in WT or KO 
Treg cells, 1 × 107 Treg cells were sorted from Foxp3IRES-YFP-Cre or 
Bcl11bf/fFoxp3IRES-YFP-Cre mice, respectively. Cells were cross-linked 
with 1% formaldehyde for 10 min, followed by addition of glycine 
to a final concentration of 0.125 M and washing two times with cold 
phosphate-buffered saline. Fixed cells were lysed for 10 min on ice 
in cell lysis buffer [25 mM Hepes (pH 7.8), 1.5 mM MgCl2, 10 mM 
KCl, 0.1% NP-40, and 1 mM dithiothreitol supplemented with 
complete protease inhibitor cocktail (Roche 05892970001)]. Chroma-
tin was sheared using a digital sonifier (Branson 450) for 5 s every 
15-s interval for 10 cycles at 10% intensity, and the sheared material 
was cleared by a 10-min centrifugation at 14,000 rpm at 4°C. The 
cleared chromatin was immunoprecipitated overnight on a rotating 
platform at 4°C with anti-Bcl11b (Bethyl Laboratories A300-385A) 
or anti-Foxp3 antibody [described in (35)] and magnetic protein A 
beads complex (Invitrogen, Dynabeads-10002D), which were pre-
conjugated for at least 6 hours, followed by extensive washing of the 
beads with ice-cold wash buffer 1 (WB1) [50 mM Hepes (pH 7.9) 
140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 
0.1% sodium dodecyl sulfate (SDS), and 1 mM phenylmethylsulfonyl 
fluoride (PMSF) (added before use)], WB2 [50 mM Hepes (pH 7.9), 
500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 
0.1% SDS, and 1 mM PMSF (added before use)], WB3 [20 mM 
tris (pH 8.0), 1 mM EDTA, 250 mM LiCl, 0.5% NP-40, 0.5% Na- 
deoxycholate, and 1 mM PMSF (added before use)], and TE [10 mM 
tris-HCl (pH 8.0) and 1 mM EDTA (pH 8.0)]. Antibody/protein/
DNA complexes were eluted from the beads, reverse cross-linked at 
65°C for 4 to 5 hours, and treated with proteinase K for 1 to 2 hours 
at 37°C (each sample). DNA from reverse cross-linked materials was 
purified using the PCR purification kit (Biofactory, GP104-100).
Purified immunoprecipitated DNA were end-repaired and size- 
selected for 200- to 400-bp fragments with Agencourt AMPure XP 
beads (A63880) followed by adenylation, barcoded adaptor ligation, 
and PCR amplification (15 cycles). ChIP-seq library for each sample 
was prepared according to the manufacturer’s (NEXTFLEX ChIP-Seq 
Kit 5143-01) protocols. Size distribution and concentration of 
each library were checked using Agilent BioAnalyzer. Equivalent 
amounts of barcoded libraries were pooled and sequenced using 
HiSeq 2500 (Illumina) instruments. To control for background 
noise, DNA was prepared from the input of each sheared chromatin 
sample, and ChIP-seq libraries were prepared and sequenced as 
described above.
Assay for transposase-accessible chromatin using 
sequencing
CD4+Foxp3+ Treg cells (1 × 105) from Bcl11b+/+Foxp3IRES-YFP-Cre or 
Bcl11bfl/flFoxp3IRES-YFP-Cre mice were used for preparation of ATAC-seq 
libraries, adapting a published protocol (36). Briefly, sorted cells 
were centrifuged and suspended in 50 l of cold hypotonic lysis 
buffer [10 mM tris-HCl (pH 7.5), 10 mM NaCl, 3 mM MgCl2, and 
0.1% NP-40], followed by immediate centrifugation at 800g for 
10 min. The pellet was resuspended in 50 l of transposition reac-
tion mix [5 l of Tagment DNA enzyme, 25 l of Tagment DNA 
buffer from the Nextera DNA Library Prep Kit (Illumina-15028212), 
and 20 l H2O] and was incubated for 10 min at 55°C for DNA to be 
Tagmented (fragmented and tagged). Tagmented DNA was cleaned 
up and purified using the Zymo Research DNA Clean & Concentrator 
kit (D4003). For library preparation, two sequential seven cycles of 
PCR were performed to enrich small tagmented DNA fragments. 
After the first PCR, the libraries were size-selected for smaller frag-
ments (around 200 to 400 bp) using Agencourt AMPure XP beads 
(A63880) followed by a second round of PCR under the same condi-
tions in order to obtain the final library. Size distribution and con-
centration of each library were checked using the Agilent High 
Sensitivity DNA Kit (5067-4626) in Agilent BioAnalyzer. Equivalent 
amounts of barcoded libraries were pooled and sequenced using 
HiSeq 2500 (Illumina) instruments to generate paired-end short 
reads (100 bp).
ChIP-seq and ATAC-seq analyses
The quality of sequenced reads (50 bp, paired-end for ChIP-seq; 
100 bp, paired-end for ATAC-seq) was measured using FastQC 
(www.bioinformatics.babraham.ac.uk/projects/fastqc/), and 
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low-quality portions of the sequenced reads were trimmed using 
Trim Galore (version 0.4.2; www.bioinformatics.babraham.ac.uk/
projects/trim:galore/) with Cutadapt (version 1.12) (MARTIN, 
Marcel. Cutadapt removes adapter sequences from high-throughput 
sequencing reads. EMBnet.journal, [S.l.], v. 17, n. 1, p. pp. 10–12, 
May 2011. ISSN 2226–6089. Available at: http://journal.embnet.
org/index.php/embnetjournal/article/view/200/479. Date accessed: 
28 Sept. 2018. doi: https://doi.org/10.14806/ej.17.1.200). The trimmed 
reads were mapped to the mouse genome (reference assembly 
mm10) using HISAT2 (version 2.1.0) (37). The mapped reads were 
sorted by genomic positions using SAMtools (version 1.3) (38), and 
duplicated mapped reads were removed using Sambamba (version 
0.6.5) (39). Biological replicates for each condition were merged, 
and the genomic binding sites (peaks) of a given protein were iden-
tified using HOMER (version 4.10.1) with an FDR-adjusted P value 
cutoff of 0.001 (40). The peaks that overlapped with the blacklisted 
regions that show anomalous, unstructured, and high signal/read 
counts (www.encodeproject.org/annotations/ENCSR636HFF/) 
were discarded. To identify reliable target genes of a given protein, 
we further removed peaks located 20 kb outside of the gene’s TSSs. 
To identify common or specific peaks between given conditions, the 
identified peaks in each condition were merged. Then, the merged 
peaks were used to define common or specific peaks using HOMER 
(getDifferentialPeaks) with default parameters, which were further 
adjusted upon manual inspection. deepTools (version 2.5.3-2-503c71b) 
(41) was used to draw heatmaps.
Enzyme-linked immunosorbent assay
Approximately 0.1 ml of serum was collected from each mouse. Se-
rum IgM and total IgG were measured using the Mouse IgM ELISA 
Ready-SET-Go! Kit (Invitrogen eBioscience-50246323) and Invitrogen 
eBioscience Mouse IgG total ELISA Ready-SET-Go! Kit (50246294), 
respectively, according to the manufacturer’s protocol. Serum IgE 
was measured using Mouse IgE ELISA MAX Standard (Bio-
Legend-432402) according to the manufacturer’s protocol.
In vitro suppression assay
Sorted CD4+YFP+ cells from Bcl11b+/+lFoxp3IRES-YFP-Cre or Bcl11bfl/fl 
Foxp3IRES-YFP-Cre mice were incubated with CD4+Foxp3−CD62Lhi 
responder cells that were prepulsed with CTV (Cell Tracking Violet) 
for 10 min at 37°C. T cell–depleted splenocytes (1 × 105 cells) were 
mixed with CTV-pulsed responder cells (5 × 104) and indicated 
ratios of Treg cells along with anti-CD3 (0.3 g/ml) and plated in 
round-bottom 96-well plates. Cells were cultured for 5 days, and 
their proliferation was analyzed by flow cytometry to determine the 
dilution and MFI of CTV intensity. CTV MFIs for responder cells 
were normalized against those for the Te-only group, where responder 
cells were plated in the absence of Treg cells.
Bioinformatics analyses
CDF curves were generated in the following way. For each gene set 
plotted, corresponding log2(fold change) values in gene expression 
for individual genes were looked up within “all genes” using “vlookup” 
function in Excel. The corresponding values were used to generate 
CDF curves in Prism 7 with the following workflow: Column anal-
ysis (Frequency distribution) > Create (Cumulative frequency 
distribution) > Tabulate [Relative frequency (fractions)] > Bin range 
(Auto) > Bin width (No beans. Tabulate exact Cumulative frequency) 
> New graph (Create a new graph of the results). Histogram of the 
data was plotted in the final graph. Some representative CDF plots 
were also cross-checked using the program “R”.
Plots depicting enrichment of ChIP-seq sites on Bcl11b-dependent 
Up or Down genes were generated by normalizing the number of 
ChIP-seq peaks within the indicated distance, every 1 kbp upstream 
or downstream of TSS of genes that fall in each category, against the 
total number of Tn/Tr-common and Tr-specific Bcl11b peaks (Fig. 4D) 
or Bcl11b-specific and Bcl11b-Foxp3-Overlapping sites (Fig. 4H).
For motif analysis, Bcl11b binding sites (peaks) located near the 
TSSs of given genes (±20 kb of TSS) were used to identify transcrip-
tion factor binding sites (motifs) using HOMER (findMotifsGenome.
pl). The length of the peak size was set to ±100 bp of the center, and 
repeat sequences in the sequences were masked (-mask option).
Statistics
Statistical analysis was performed with GraphPad Prism 7.0 (GraphPad 
software, La Jolla, CA, USA) using unpaired two-tailed Student’s 
t test, Wilcoxon rank-sum test, or Kolmogorov-Smirnov test where 
applicable. Statistically significant differences in mean values were 
considered at P < 0.05.
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